
    
      An open-label, balanced, randomized, two-treatment, two-sequence, two-period, single-dose,
      crossover oral bioequivalence study of Paricalcitol Capsules 4 mcg of Dr. Reddy's
      Laboratories Limited and ZemplarÂ® Capsules 4 mcg of Abbott Laboratories, USA in healthy,
      adult, human subjects under fasting conditions.
    
  